Zhang et al. down-regulated XBP1 by shRNA and showed that it reduced ovarian cancer cell viability and enhanced sensitivity to oxidative stress by increasing intracellular ROS levels (Zhang et al., 2019[43]). Here, XBP1 is linked to ovarian carcinoma.